Equibles does not estimate personal net worth.
Get an email with a short summary when Korro Bio, Inc. publishes a filing, an earnings call transcript or a press release.
Get KRRO alertsRam Aiyar is recorded as CFO at Korro Bio, Inc. (KRRO) since October 17, 2025, Board Member at Korro Bio, Inc. (KRRO) since November 3, 2023 and CEO at Korro Bio, Inc. (KRRO). Korro Bio, Inc. reported in an 8-K filed October 8, 2025 that Ram Aiyar was appointed interim Chief Financial Officer and principal financial officer, effective October 17, 2025. Korro Bio, Inc. reported in an 8-K filed February 11, 2025 that Ram Aiyar was appointed interim principal financial officer, effective February 11, 2025. Korro Bio, Inc. reported in an 8-K filed November 6, 2023 that Ram Aiyar was appointed President and Chief Executive Officer and principal executive officer, effective November 3, 2023. Equibles holds 4 filed executive changes naming Ram Aiyar; each is listed under recent activity with its source filing. The proxy statement of Korro Bio, Inc. reports total compensation of $3,119,591 for Ram Aiyar in fiscal 2025, including a base salary of $633,200. Disclosed compensation is on record for 4 fiscal years. Korro Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Korro Bio, Inc. includes Christopher Loose (CEO), David L. Lucchino (CEO and Board Member), Nessan Bermingham (Chairman and Board Member) and 7 others.
“the Board appointed Dr. Ram Aiyar, President and Chief Executive Officer (principal executive officer), to serve as Korro's interim Chief Financial Officer and principal financial officer, in addition to his current duties effective from October 17, 2025.”
“effective from February 11, 2025, Korro's Board of Directors appointed Dr. Ram Aiyar, President and Chief Executive Officer (principal executive officer), to serve as Korro's interim principal financial officer, and Mr. Oliver Dolan, Senior Vice President, Finance, to serve as Korro's interim principal accounting officer, in each case, in addition to their current duties.”
2025-10-17–present
2023-11-03–present
KRRO
Biotechnology · Healthcare
CEO, CFO, Board Member
2023-11-03–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Korro Bio, Inc. (KRRO) | Chief Executive Officer, President and Interim Chief Financial Officer | $633,200 | $3,119,591 |
| 2024 | Korro Bio, Inc. (KRRO) | Chief Executive Officer and President | $610,000 | $939,075 |
| 2023 | Korro Bio, Inc. (KRRO) | Chief Executive Officer and President | $498,487 | $2,858,230 |
| 2022 | Korro Bio, Inc. (KRRO) | Chief Executive Officer and President | $472,500 | $1,196,545 |
